Table 1 Clinicopathological significance of PSD3 expression in ESCC by χ2 test.
Characteristics | Cases | PSD3 expression | χ2 | p | |
|---|---|---|---|---|---|
High | Low | ||||
Type | Â | Â | Â | Â | Â |
ESCC | 114 | 83 | 31 | 35.192 | 0.000 |
NAT | 66 | 18 | 48 | ||
Gender | Â | Â | Â | Â | Â |
Male | 84 | 65 | 19 | 3.373 | 0.066 |
Fmale | 30 | 18 | 12 | ||
Age (year) | Â | Â | Â | Â | Â |
\(\geqq\)Â 60 | 83 | 59 | 24 | 0.458 | 0.499 |
< 60 | 31 | 24 | 7 | ||
Differentiation degree | Â | Â | Â | Â | Â |
Well | 8 | 8 | 0 | 5.631 | 0.060 |
Moderate | 82 | 61 | 21 | ||
Poor | 24 | 14 | 10 | Â | Â |
T classification | Â | Â | Â | Â | Â |
T1-T2 | 29 | 19 | 10 | 1.044 | 0.307 |
T3-T4 | 85 | 64 | 21 | ||
N classification | Â | Â | Â | Â | Â |
N0 | 53 | 33 | 20 | 5.561 | 0.018 |
N1-N3 | 61 | 50 | 11 | ||
Gross classification type | Â | Â | Â | Â | Â |
Ulcerative | 70 | 50 | 20 | 4.565 | 0.169 |
Protrude | 7 | 3 | 4 | ||
Medullar | 33 | 26 | 7 | ||
Shrinkage | 4 | 4 | 0 | ||
